Patent Assignment
Reel/Frame 017115/0658
Security Agreement
Recorded: 2005-12-14
Pages: 23
Assignor
KIEL LABORATORIES, INC.
Executed: 2005-06-29
Assignee
WACHOVIA BANK, NATIONAL ASSOCIATION
191 PEACHTREE STREET, ATLANTA, GEORGIA, 30303
Covered Properties
(21)
Lice Removing Composition
Patent:
6,350,724 →
Application:
09/373,951 →
Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
Application:
10/047,578 →
Publication:
US 2003/0083354
Process for Preparing Tannate Liquid and Semi-Solid Dosage Forms
Process for Preparing Tannate Tablet, Capsule or Other Solid Dosage Forms
Diphenhydramine tannate compositions and methods of use
Application:
10/489,135 →
Publication:
US 2004/0234593
Diphenhydramine tannate solid dose compositions and methods of use
Application:
10/505,347 →
Publication:
US 2005/0069584
Diphenhydramine tannate liquid and semi-solid compositions and methods of use
Application:
10/505,355 →
Publication:
US 2005/0069585
Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
Application:
10/645,977 →
Publication:
US 2004/0132827
Single tank process for preparing tannate liquid and semi-solid dosage forms
Application:
10/799,302 →
Publication:
US 2005/0202050
Phenolic Acid Salts of Gabapentin in Solid Dosage Forms and Methods of Use
Process for Preparing Phenolic Acid Salts of Gabapentin
Phenolic Acid Salts of Gabapentin in Liquid and/or Semi-Solid Dosage Forms and Methods of Use
Process for Preparing Tannate Liquid and Semi-Solid Dosage Forms
In process conversion method for preparing tannate tablet, capsule or other solid dosage forms
Application:
11/078,854 →
Publication:
US 2005/0202080
Process for preparing tannate suspensions
Application:
60/282,969 →
Process for preparing tannate tablets and dosage forms
Application:
60/328,990 →
Gabapentin tannate solid dosage forms and methods of use
Application:
60/457,399 →
Gabapentin tannate liquid and/or semi-solid dosage forms and methods of use
Application:
60/457,408 →
Process for preparing gabapentin tannate
Application:
60/457,431 →
In process conversion method for preparing tannate table, capsule, or other solid dosage forms
Application:
60/552,519 →
Phenolic acid complexes of hyoscyamine and process for preparing the same
Application:
60/636,191 →
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 15, 1999
From: KIEL, JEFFREY S.; PING, JEFFREY H.
To: EFFCON LABORATORIES, INC.
Reel/Frame 010230/0160 →
Assignment of Assignor's Interest
Oct 26, 2001
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARASIMHAN
To: PEDIAMED PHARMACEUTICALS, INC.
Reel/Frame 012517/0195 →
Assignment of Assignor's Interest
May 8, 2002
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARASIMHAN
To: KIEL LABORATORIES, INC.
Reel/Frame 012887/0734 →
Assignment of Assignor's Interest
Oct 10, 2002
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARASHIMHAN
To: KIEL LABORATORIES, INC.
Reel/Frame 013390/0958 →
Assignment of Assignor's Interest
Aug 12, 2004
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARASIMHAN
To: KIEL LABORATORIES, INC.
Reel/Frame 014986/0279 →
Assignment of Assignor's Interest
Aug 27, 2004
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARASIMHAN
To: KIEL LABORATORIES, INC.
Reel/Frame 015089/0420 →
Security Interest
Oct 22, 2004
From: PERIAMED PHARMACEUTICALS, INC.
To: US BANK NATIONAL ASSOCIATION
Reel/Frame 015908/0004 →
Assignment of Assignor's Interest
Jan 6, 2005
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARSIMHAN
To: KIEL LABORATORIES, INC.
Reel/Frame 015553/0937 →
Assignment of Assignor's Interest
Jan 6, 2005
From: KIEL, JEFFREY S.; THOMAS, H. GREG; MANI, NARSIMHAN
To: KIEL LABORATORIES, INC.
Reel/Frame 015553/0930 →
Assignment of Assignor's Interest
Apr 21, 2005
From: WARE, EMILY C.; KIEL, JEFFREY S.; THOMAS, H. GREG; WARE, BRADY NEAL
To: KIEL LABORATORIES, INC.
Reel/Frame 016131/0449 →
Corrective Assignment to Correct Previously Recorded Assignment (Reel 015908/Frame 004)
May 20, 2005
From: PEDIAMED PHARMACEUTICALS, INC.
To: US BANK NATIONAL ASSOCIATION
Reel/Frame 016263/0283 →
Release of Security Interest
Apr 18, 2006
From: U.S. BANK NATIONAL ASSOCIATION
To: PEDIAMED PHARMACEUTICALS, INC
Reel/Frame 017823/0652 →
Assignment of Assignor's Interest
Jan 18, 2007
From: PEDIAMED PHARMACEUTICALS, INC.
To: TIBER LABORATORIES, LLC
Reel/Frame 018777/0857 →
Assignment of Assignor's Interest
Jan 19, 2007
From: PEDIAMED PHARMACEUTICALS, INC.
To: TIBER LABORATORIES, LLC
Reel/Frame 018787/0028 →
Release of Security Interest
Aug 25, 2010
From: WELLS FARGO BANK, N.A., SUCCESSOR IN INTEREST BY MERGER TO WACHOVIA BANK, NATIONAL ASSOCIATION
To: KIEL LABORATORIES, INC.
Reel/Frame 024879/0390 →
Assignment of Assignor's Interest
Sep 7, 2010
From: KIEL LABORATORIES, INC.
To: PERNIX THERAPEUTICS, LLC
Reel/Frame 024933/0951 →
Security Agreement
Jan 3, 2013
From: PERNIX THERAPEUTICS, LLC
To: MIDCAP FUNDING V, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 029567/0694 →
Release of Security Interest in Patent Rights Reel/Frame 029567/0694
Feb 24, 2014
From: MIDCAP FUNDING IV, LLC (SUCCESSOR IN INTEREST TO MIDCAP FUNDING V, LLC)
To: PERNIX THERAPEUTICS, LLC
Reel/Frame 032330/0037 →
Assignment of Assignor's Interest
May 31, 2019
From: PERNIX THERAPEUTICS, LLC
To: CURRAX PHARMACEUTICALS LLC
Reel/Frame 049329/0657 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →